ZDHHC21 and acute myeloid leukemia: zDHHC21 inhibition reduced the growth of patient‐derived AML blasts injected in mice and sensitized AML blasts to the cytotoxic effects of chemotherapy in xenograft model of relapsed/refractory leukemia, highlighting the potential of zDHHC21 as a potential therapeutic target in AML.